Diagnostics & Testing

Radiometer is a Danish medical device company specializing in acute care diagnostics, including blood gas, blood sampling, transcutaneous monitoring, immunoassay testing and related IT systems. From its Copenhagen headquarters, and as part of Danaher’s Diagnostics segment, it delivers integrated point‑of‑care solutions for emergency, intensive care and neonatal intensive care environments worldwide.

Radiometer is a Danaher subsidiary specializing in acute care diagnostics, including blood gas analysis, blood sampling, transcutaneous monitoring and point-of-care IT solutions. Radiometer America supports North American hospitals and critical care providers with integrated analyzers, consumables and connectivity tools designed to streamline workflows, standardize blood gas testing and support regulatory and IT integration needs.

Rapid Infection Diagnostics (MeMed) develops rapid host‑immune response diagnostics that distinguish bacterial from viral infections in minutes. Its FDA‑cleared MeMed BV® test, run on the MeMed Key® platform, is clinically validated in over 20,000 patients and supports antimicrobial stewardship and improved management of acute infections.

Roche is a Basel‑based global healthcare leader in in‑vitro diagnostics and biotechnology, integrating diagnostics, medicines and digital solutions across major disease areas. Its diagnostics division delivers tens of billions of tests annually and supports early detection, precise diagnosis and monitoring, making Roche a key strategic partner for laboratory, hospital and pharma R&D procurement teams worldwide.

SCIEX is a Danaher life-science company providing LC‑MS, CE instruments, clinical IVD mass spectrometers, HPLC‑MS front-ends, software and integrated workflows for pharma, biopharma, clinical and analytical laboratories. Its portfolio supports precise quantitation, characterization and routine testing across applications including diagnostics, environmental, food, forensics and life science research.

Shimadzu Corporation is a Kyoto-based public manufacturer of analytical instruments, medical imaging systems, and industrial equipment used widely in pharma R&D and QC. It offers chromatography, mass spectrometry, spectroscopy, and diagnostic platforms, supported by global collaboration labs and innovation centers focused on advanced healthcare, biopharmaceuticals, food science, and environmental applications.

SWISSCI Laboratory Solutions is a UK-based specialist manufacturer of precision laboratory consumables for crystallography, cryo-EM, ultrafiltration, dialysis, and crystal imaging workflows. The company serves pharmaceutical R&D and structural biology markets with application-specific labware including MRC crystallization plates, cryo-EM grid boxes, Converse ultrafiltration devices, and UVEX imaging systems.

QIAGEN is a global provider of Sample to Insight solutions spanning sample prep, PCR and NGS reagents, automated instruments, digital PCR and bioinformatics for research and diagnostics. It supports pharma, biotech and clinical labs with oncology, infectious disease, TB, microbiome and human ID workflows, complemented by AI tools, configurators, knowledge resources and services for end-to-end workflow optimization.

QIAGEN is a global provider of integrated “Sample to Insight” solutions spanning sample processing, assays, automation, and bioinformatics for molecular diagnostics and life science R&D. Its portfolio includes clinical nucleic acid extraction platforms, digital PCR systems, NGS panels and library kits, human ID and infectious disease tools, and AI-enabled workflow configurators supporting pharma, biotech and clinical labs.

Scale Biosciences is a San Diego–based biotechnology company providing scalable single cell library preparation kits, multiplexing solutions, and workflows that enable high-throughput single cell omics on standard lab equipment. Its QuantumScale Single Cell RNA and methylation kits, powered by Quantum Barcoding and ScalePlex multiplexing, support cost-effective experiments from hundreds to millions of cells and thousands of samples for disease biology, biomarker, and drug discovery research.

SeekGene is a Beijing‑based private biotechnology company specializing in high‑throughput single‑cell and spatial multi‑omics platforms built around its SeekOne DD digital droplet system and SeekSpace spatial transcriptomics solutions. It provides instruments, reagents, and cloud‑enabled analysis software that together support single‑cell RNA, ATAC, methylation, immune repertoire, and spatial sequencing workflows for pharma, biotech, and academic research.

Seer is a public proteomics technology company providing the Proteograph® Product Suite for deep, unbiased, high-throughput proteomic discovery. Its nanoparticle-based, mass spectrometry workflow and analysis software support cohort-scale biomarker and translational studies, available as in-house systems, projects via the Seer Technology Access Center, or through certified service providers.

Seer Inc. is a public proteomics technology company offering the Proteograph Product Suite, an integrated nanoparticle-based, automated, and software-enabled workflow for deep, unbiased, high-throughput mass spec proteomics. Its platforms and services support plasma proteomics, biomarker discovery and large-scale translational studies via in-house systems, Seer’s Technology Access Center, or certified service providers, for research use only.

Signios Bio (Signios Biosciences) is a Foster City, California–based, MedGenome-powered multiomics and NGS service provider offering end-to-end genomics, transcriptomics, proteomics and spatial biology services plus AI-driven bioinformatics. It supports pharma, biotech, CROs and academia from study design through sequencing and data interpretation across oncology, immunology, rare and complex diseases, and Dx/CDx development.

Mission Bio provides the Tapestri single-cell multi-omics platform, enabling simultaneous DNA, RNA, and protein analysis from individual cells to resolve clonal heterogeneity in cancer and genome-edited products. Pharma and biotech teams use Tapestri instruments, panels, and bioinformatics for hematologic malignancies, solid tumors, and CRISPR QC, supporting biomarker discovery and patient stratification.

Bruker Cellular Analysis offers live single-cell functional analysis platforms for pharma and biotech R&D, centered on Beacon optofluidic systems and proteomic barcoding. It supports antibody discovery, T-cell profiling, cell line development, and translational single-cell proteomics workflows.

Quantum-Si provides Platinum and Platinum Pro benchtop instruments for single-molecule next-generation protein sequencing with single-amino-acid resolution. Their platforms integrate streamlined sample prep, sequencing, and flexible data analysis to support protein identification, variant and proteoform analysis, post-translational modification characterization, antibody sequencing, and protein barcoding in research and drug discovery environments.

Nautilus Biotechnology develops the Voyager™ single-molecule proteomics platform, combining integrated reagents, flow cells, imaging, machine learning and cloud analysis to perform Iterative Mapping of billions of proteins and proteoforms per run. The system delivers reproducible digital counts with broad proteome coverage to support drug development, biomarker discovery and exploratory biology.

SomaLogic is a proteomics company, now part of Illumina, that provides high‑plex, high‑throughput protein measurement technologies and services. Its SomaScan platform and SOMAmer reagents enable up to 11,000 protein measurements from small samples, supported by CLIA‑certified assay services, global authorized sites, and data analysis tools for biomarker discovery and diagnostics development.

Spear Bio develops ultrasensitive SPEAR immunoassay technology for single-molecule protein biomarker detection in minimal sample volumes. The ISO 13485:2016 certified company serves pharmaceutical R&D and diagnostics markets with assays for neurodegenerative disease biomarkers including pTau 217, GFAP, and Nf-L.

SphingoTec GmbH is a private diagnostics company in Hennigsdorf near Berlin that develops novel blood-based protein biomarkers for acute and critical care, such as acute kidney injury, sepsis, and acute heart failure. It commercializes assays like sphingotest® penKid® and bio‑ADM® as microtiter plate and ELISA tests, and out-licenses its proprietary biomarkers to IVD and pharma partners for clinical diagnostics and critical care drug development.

Standard BioTools Inc. is a public life science tools company providing leading proteomic, genomic and multi‑omic solutions, including CyTOF, Hyperion and Biomark platforms. Their research‑use‑only instruments, assays and lab services support high‑parameter immune profiling, spatial biology and high‑throughput genomics for biomarker discovery, drug development and clinical research applications across global pharma, biotech and academic markets.

Syndex Bio is a Cambridge, UK–based biotech company developing mcPCR, a proprietary methyl-copying PCR platform that preserves DNA methylation during amplification for high-sensitivity diagnostics. The patented, non-destructive, high-throughput workflow integrates into genomic and multi-omic analyses for oncology, early cancer detection, residual disease monitoring, and patient stratification from low-input clinical samples.

TATAA Biocenter is a GLP-accredited molecular bioanalytical CRO specializing in PCR, NGS and proteomics for advanced therapies. It delivers compliant bioanalysis and biomarker assay services for gene therapies, RNA therapeutics and other modalities, backed by proprietary short RNA quantification technologies and extensive regulatory-aligned assay development expertise.